IP Library Granted Patent US 12,002,595
Granted Patent B2
US 12,002,595 · App. 16/365,132 · Granted Jun 4, 2024

Separation of metal ions by liquid-liquid extraction

Inventors: Rebecca J. Abergel (Oakland, CA); Gauthier J. P. Deblonde (Oakland, CA); Abel Ricano (Oakland, CA)
Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
G21F9/125G21C19/46G21F9/00C07K14/47Y02W30/50
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,002,595
App. No.
16/365,132
Granted
Jun 4, 2024
Kind
B2
Abstract

Provided herein are separation processes for metal ions present in aqueous solutions based on methods involving liquid-liquid extraction. The separation process involves a chelator that can selectively bind to at least one of the metals at a relatively low pH. This can be used, for example, for recovery and purification of actinides from lanthanides, separation of metal ions based on their valence, and separation of metal ions based on the pH of the extraction conditions.

Claims (20)

1. A method of separating metal ions, comprising:

contacting a liquid composition comprising a plurality of metal ions with an octadentate ligand, under conditions sufficient to form a metal ion-ligand complex comprising a metal ion of the plurality of metal ions, to generate a mixture enriched for the metal ion-ligand complex; and

separating a first fraction of the mixture enriched for the metal ion-ligand complex from a second fraction depleted for the metal ion-ligand complex, wherein the first fraction of the mixture has an acidic pH of less than 1,

wherein the plurality of metal ions are plutonium ions.

2. The method of claim 1 , wherein acidic denotes a pH of between about 1 to about 0.

3. The method of claim 1 , wherein the octadentate ligand is a hydroxypyridonate ligand.

4. The method of claim 3 , wherein the octadentate ligand is built on a spermine scaffold.

5. The method of claim 3 , wherein the octadentate ligand is 3,4,3-LI(1,2-HOPO).

6. The method of claim 1 , further comprising dissolving a metal in an acidic solution to obtain the liquid composition.

7. The method of claim 1 , further comprising lowering a pH beneath 0 to separate tetravalent ions.

8. The method of claim 1 , further comprising an extractant.

9. The method of claim 8 , wherein the extractant is selected from the group consisting of TODGA, di-(2-ethylhexyl)phosphoric acid (HDEHP), a derivative of HDEHP, calixarenes, diglycoamide derivatives, carbamoylphosphine oxide derivatives, tributylphosphate (TBP), monoamide derivatives, and tertiary amines, and quaternary ammonium salts.

10. The method of claim 1 , wherein separating comprises filtering, precipitating, liquid-liquid extraction or chromatography, or wherein the method further comprises filtering, precipitating, liquid-liquid extraction or chromatography.

11. The method of claim 1 , wherein

1) the separating comprises contacting the liquid composition with an organic phase or

2) further comprising contacting the liquid composition with an organic phase.

12. The method of claim 6 , wherein the method does not comprise adjusting the pH of the liquid composition after dissolving the metal.

13. The method of claim 6 , wherein the method does not comprise raising the pH of the liquid composition after dissolving the metal.

14. The method of claim 11 , wherein the organic phase comprises a non-selective extractant.

15. The method of claim 11 , wherein the organic phase does not comprise an extractant that selectively binds to the first or second fraction.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 10, 2022
From: FRED HUTCHINSON CANCER CENTER
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 061724/0791 →
MERGER AND CHANGE OF NAME Recorded Oct 27, 2022
From: FRED HUTCHINSON CANCER RESEARCH CENTER; SEATTLE CANCER CARE ALLIANCE
To: FRED HUTCHINSON CANCER CENTER
Reel/Frame 061792/0210 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2021
From: STRONG, ROLAND K.
To: FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 055788/0363 →
CONFIRMATORY LICENSE Recorded Jun 13, 2019
From: UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB
To: UNITED STATES DEPARTMENT OF ENERGY
Reel/Frame 049460/0368 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2019
From: ABERGEL, REBECCA J.; DEBLONDE, GAUTHIER JP; RICANO, ABEL
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 049438/0012 →
Continuity (4)
Continuation In Part PCTUS2017048934 · Aug 28, 2017
Provisional Application 62505458 · May 12, 2017
Provisional Application 62401687 · Sep 29, 2016
Related Publication 20190287691A1 · Sep 19, 2019
Cited By (2)
US 12,268,678 US 12,479,792